Thus, these data suggest that FAS, SCD1, SCAD and PPARα, as factors downstream of PCSK9, mediated the effects of metformin in olanzapine-induced NAFLD. The gene discussed is FAS; the disease is metabolic dysfunction-associated steatotic liver disease.